Molecular profiling of metastatic lung squamous cell carcinoma (mLUSC) to identify patients with differential response to immune checkpoint inhibitor (ICI) therapy.

Authors: Daniel Boiarsky, Lingzhi Hong, Alissa Jamie Cooper, Biagio Ricciuti, Maliazurina B. Saad, Arielle Elkrief, Alessandro Di Federico, Muhammad Aminu, Waree Rinsurongkawong, Jeff Lewis, Don Lynn Gibbons, Ara A. Vaporciyan, Xiuning Le, J. Jack Lee, John Heymach, Jia Wu, Mark M. Awad, Adam Jacob Schoenfeld, Jianjun Zhang, Natalie I Vokes

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20555

Source: Full article

---

Abstract

e20555